AssetMark Inc’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.9K | Sell |
13,914
-542
| -4% | -$932 | ﹤0.01% | 1764 |
|
|
2025
Q1 | $48.1K | Buy |
14,456
+2,397
| +20% | +$7.98K | ﹤0.01% | 1449 |
|
|
2024
Q4 | $89.2K | Sell |
12,059
-794
| -6% | -$5.88K | ﹤0.01% | 1277 |
|
|
2024
Q3 | $121K | Buy |
12,853
+4,167
| +48% | +$39.1K | ﹤0.01% | 1117 |
|
|
2024
Q2 | $69.7K | Buy |
8,686
+2,736
| +46% | +$21.9K | ﹤0.01% | 1171 |
|
|
2024
Q1 | $88.2K | Sell |
5,950
-3,580
| -38% | -$53.1K | ﹤0.01% | 1065 |
|
|
2023
Q4 | $77.5K | Buy |
9,530
+654
| +7% | +$5.32K | ﹤0.01% | 1076 |
|
|
2023
Q3 | $40.4K | Buy |
8,876
+2,718
| +44% | +$12.4K | ﹤0.01% | 1140 |
|
|
2023
Q2 | $43.4K | Buy |
6,158
+1,935
| +46% | +$13.6K | ﹤0.01% | 1114 |
|
|
2023
Q1 | $25.8K | Buy |
4,223
+3,166
| +300% | +$19.3K | ﹤0.01% | 1157 |
|
|
2022
Q4 | $6.75K | Buy |
1,057
+233
| +28% | +$1.49K | ﹤0.01% | 1327 |
|
|
2022
Q3 | $8K | Buy |
824
+329
| +66% | +$3.19K | ﹤0.01% | 1247 |
|
|
2022
Q2 | $5K | Buy |
495
+231
| +88% | +$2.33K | ﹤0.01% | 1303 |
|
|
2022
Q1 | $4K | Buy |
+264
| New | +$4K | ﹤0.01% | 1316 |
|